Transcription factors as targets for cancer therapy - PubMed (original) (raw)

Review

doi: 10.1038/nrc906.

Affiliations

• PMID: 12360277
• DOI: 10.1038/nrc906

Review

Transcription factors as targets for cancer therapy

James E Darnell Jr. Nat Rev Cancer. 2002 Oct.

Abstract

A limited list of transcription factors are overactive in most human cancer cells, which makes them targets for the development of anticancer drugs. That they are the most direct and hopeful targets for treating cancer is proposed, and this is supported by the fact that there are many more human oncogenes in signalling pathways than there are oncogenic transcription factors. But how could specific transcription-factor activity be inhibited?

PubMed Disclaimer

Similar articles

• Wnt breakers in colon cancer.
  Clevers H. Clevers H. Cancer Cell. 2004 Jan;5(1):5-6. doi: 10.1016/s1535-6108(03)00339-8. Cancer Cell. 2004. PMID: 14749120 Review.
• Kaposi virus scores cancer coup.
  Boshoff C. Boshoff C. Nat Med. 2003 Mar;9(3):261-2. doi: 10.1038/nm0303-261. Nat Med. 2003. PMID: 12612569 No abstract available.
• Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
  Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR, Fearon ER. Leung JY, et al. J Biol Chem. 2002 Jun 14;277(24):21657-65. doi: 10.1074/jbc.M200139200. Epub 2002 Apr 8. J Biol Chem. 2002. PMID: 11940574
• The Wnt signalling pathway.
  Hlsken J, Behrens J. Hlsken J, et al. J Cell Sci. 2000 Oct;113 ( Pt 20):3545. doi: 10.1242/jcs.113.20.3545. J Cell Sci. 2000. PMID: 11017867 No abstract available.
• Wnt signalling: a theme with nuclear variations.
  Sharpe C, Lawrence N, Martinez Arias A. Sharpe C, et al. Bioessays. 2001 Apr;23(4):311-8. doi: 10.1002/bies.1045. Bioessays. 2001. PMID: 11268036 Review.

Cited by

• Targeting the interleukin-6/Jak/stat pathway in human malignancies.
  Sansone P, Bromberg J. Sansone P, et al. J Clin Oncol. 2012 Mar 20;30(9):1005-14. doi: 10.1200/JCO.2010.31.8907. Epub 2012 Feb 21. J Clin Oncol. 2012. PMID: 22355058 Free PMC article. Review.
• A STAT3 Gene Expression Signature in Gliomas is Associated with a Poor Prognosis.
  Alvarez JV, Mukherjee N, Chakravarti A, Robe P, Zhai G, Chakladar A, Loeffler J, Black P, Frank DA. Alvarez JV, et al. Transl Oncogenomics. 2007 Nov 11;2:99-105. doi: 10.4137/tog.s1903. Print 2007. Transl Oncogenomics. 2007. PMID: 23641147 Free PMC article.
• The SIX1-EYA transcriptional complex as a therapeutic target in cancer.
  Blevins MA, Towers CG, Patrick AN, Zhao R, Ford HL. Blevins MA, et al. Expert Opin Ther Targets. 2015 Feb;19(2):213-25. doi: 10.1517/14728222.2014.978860. Epub 2015 Jan 2. Expert Opin Ther Targets. 2015. PMID: 25555392 Free PMC article. Review.
• Exploring Thiazolopyridine AV25R: Unraveling of Biological Activities, Selective Anti-Cancer Properties and In Silico Target and Binding Prediction in Hematological Neoplasms.
  Ladwig A, Gupta S, Ehlers P, Sekora A, Alammar M, Koczan D, Wolkenhauer O, Junghanss C, Langer P, Murua Escobar H. Ladwig A, et al. Molecules. 2023 Dec 15;28(24):8120. doi: 10.3390/molecules28248120. Molecules. 2023. PMID: 38138609 Free PMC article.
• Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts.
  Zhang X, Yue P, Page BD, Li T, Zhao W, Namanja AT, Paladino D, Zhao J, Chen Y, Gunning PT, Turkson J. Zhang X, et al. Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9623-8. doi: 10.1073/pnas.1121606109. Epub 2012 May 23. Proc Natl Acad Sci U S A. 2012. PMID: 22623533 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal